FDA Addresses Breast Cancer in Men.
Research on breast cancer is rapidly progressing, leading to new therapies and treatment approaches, yet in men with the disease it continues to lag. Recently, the FDA released a draft guidance to address this disparity, outlining strategies to improve drug development for men such as including them in clinical trials and using nontraditional data sources.